Regulatory Updates
🇺🇸 FDA Page 13FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 145–156 of 382 articles
Personalized mRNA Cancer Vaccines: A New Era for Melanoma Treatment
melanoma · 7 min
Dr. Sarah MitchellCumberland Pharmaceuticals (NASDAQ: CPIX) to divest marketed brands to Apotex for $100M
FDA · 10 min
Dr. Sarah MitchellNavigating the Regulatory Landscape: A Strategic Policy Agenda for Private Equity in Healthcare
8 min
Dr. Sarah MitchellFDA grants orphan status to oxaliplatin for hard-to-treat pancreatic cancer
FDA · pancreatic cancer · 9 min
Dr. Sarah MitchellGilead Secures First Hepatitis D Drug Approval, Sparking Bay Area Competition
FDA · hepatitis · 9 min
Dr. Sarah MitchellFDA Approves MannKind's Afrezza for Pediatric Diabetes Patients
FDA · diabetes · 7 min
Dr. Sarah MitchellElite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
U.S. Food and Drug Administration · 10 min
Dr. Sarah MitchellAbbVie's Decnupaz Secures FDA Approval for Rare Blood Cancer
FDA · blastic plasmacytoid dendritic cell neoplasm · 5 min
Dr. Sarah MitchellEli Lilly's Retatrutide Success Amidst Regulatory Shifts: A Strategic Analysis
FDA · 9 min
Dr. Sarah MitchellFDA Expands ENDS Market Access: Implications for Pharma BD and Investors
FDA · 8 min
Dr. Sarah MitchellAmgen and Zai Lab Leadership Shifts: Strategic Implications for Pharma BD and Investors
FDA · neurology · 8 min
Dr. Sarah MitchellFDA Approves Atezolizumab for ctDNA MRD-Positive MIBC: A New Era for Adjuvant Therapy
FDA · muscle invasive bladder cancer · 7 min
Dr. Sarah MitchellExplore intelligence